Atrial fibrillation in Sub-Saharan Africa: epidemiology, unmet needs, and treatment options

References

• World BankDisease Control Priorities in Developing Countries2nd edWashington, DCWorld Bank2006
   Google Scholar
• SliwaKCarringtonMJKlugEPredisposing factors and incidence of newly diagnosed atrial fibrillation in an urban African community: insights from the Heart of Soweto StudyHeart201096231878188221062777
   PubMed Web of Science ®Google Scholar
• FusterVRydénLECannomDSAmerican College of Cardiology Foundation/American Heart Association Task Force2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelinesCirculation201112310e269e36721382897
   PubMed Web of Science ®Google Scholar
• United Nations Department of Economic and Social Affairs Population Division 2013World Population Prospects: The 2012 Revision Special Aggregates – DVD-ROM Edition – Dataset in Excel Format (United Nations Publication ST/ESA/SER.A/335)2014 Available from: http://esa.un.org/unpd/wpp/SpecialAggregates/DISK_NAVIGATION_EXCEL_Geographical.htmAccessed September 2, 2014
   Google Scholar
• BloomfieldGSBarasaFADollJAVelazquezEJHeart failure in sub-Saharan AfricaCurr Cardiol Rev20139215717323597299
   PubMedGoogle Scholar
• DamascenoAMayosiBMSaniMThe causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countriesArch Intern Med2012172181386139422945249
   PubMedGoogle Scholar
• MoranAForouzanfarMSampsonUChughSFeiginVMensahGThe epidemiology of cardiovascular diseases in sub-Saharan Africa: the global burden of diseases, injuries and risk factors 2010 studyProg Cardiovasc Dis201356323423924267430
   PubMed Web of Science ®Google Scholar
• RahmanFKwanGFBenjaminEJGlobal epidemiology of atrial fibrillationNat Rev Cardiol2014111163965425113750
   PubMed Web of Science ®Google Scholar
• HannonNSheehanOKellyLStroke associated with atrial fibrillation – incidence and early outcomes in the north Dublin population stroke studyCerebrovasc Dis2010291434919893311
   PubMed Web of Science ®Google Scholar
• LinHJWolfPAKelly-HayesMStroke severity in atrial fibrillation. The Framingham StudyStroke19962710176017648841325
   PubMed Web of Science ®Google Scholar
• CammAJKirchhofPLipGYGuidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)Eur Heart J201031192369242920802247
   PubMed Web of Science ®Google Scholar
• FeiginVLForouzanfarMHKrishnamurthiRGlobal Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) and the GBD Stroke Experts GroupGlobal and regional burden of stroke during 1990–2010 findings from the Global Burden of Disease Study2010Lancet2014383991324525424449944
   PubMed Web of Science ®Google Scholar
• AndersonNFullerRDudleyN‘Rules of thumb’ or reflective practice? Understanding senior physicians’ decision-making about anti-thrombotic usage in atrial fibrillationQJM2007100526326917389657
   PubMed Web of Science ®Google Scholar
• BakerWLCiosDASanderSDColemanCIMeta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United StatesJ Manag Care Pharm200915324425219326955
   PubMed Web of Science ®Google Scholar
• Ntep-GwethMZimmermannMMeiltzAAtrial fibrillation in Africa: clinical characteristics, prognosis, and adherence to guidelines in CameroonEuropace201012448248720179174
   PubMed Web of Science ®Google Scholar
• NguyenTNHilmerSNCummingRGReview of epidemiology and management of atrial fibrillation in developing countriesInt J Cardiol201316762412242023453870
   PubMed Web of Science ®Google Scholar
• CoulibalyIAnzouan-KacouJBKoninKCKouadioSCAbouo-N’DoriRFibrillation auriculaire: epidémiologie i l’institut de cardiologie d’Abidjan (Côte d’Lvoire) [Atrial fibrillation: epidemiological data from the Cardiology Institute in Abidjan, Cote d’Ivoire]Med Trop (Mars)201070437137422368936
   PubMedGoogle Scholar
• MbayeAPessinabaSBodianMLa fibrillation atriale, fréquence, facteurs étiologiques, évolution et traitement dans un service de cardiologie de Dakar, Sénégal [Atrial fibrillation, frequency, etiologic factors, evolution and treatment in a cardiology department in Dakar, Senegal]Pan Afr Med J201061622087349
   PubMedGoogle Scholar
• ShavadiaJYongaGMwanziSJinahAMoriasiAOtienoHClinical characteristics and outcomes of atrial fibrillation and flutter at the Aga Khan University Hospital, NairobiCardiovasc J Afr20132426923612946
   PubMed Web of Science ®Google Scholar
• DewhurstMJAdamsPCGrayWKStrikingly low prevalence of atrial fibrillation in elderly TanzaniansJ Am Geriatr Soc20126061135114022646732
   PubMed Web of Science ®Google Scholar
• MiyasakaYBarnesMEGershBJSecular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalenceCirculation2006114211912516818816
   PubMed Web of Science ®Google Scholar
• Lloyd-JonesDAdamsRJBrownTMAmerican Heart Association Statistics Committee and Stroke Statistics SubcommitteeHeart disease and stroke statistics – 2010 update: a report from the American Heart AssociationCirculation20101217e46e21520019324
   PubMed Web of Science ®Google Scholar
• AlonsoAAgarwalSKSolimanEZIncidence of atrial fibrillation in whites and African-Americans: the atherosclerosis risk in communities (ARIC) studyAm Heart J2009158111111719540400
   PubMed Web of Science ®Google Scholar
• HuxleyRRLopezFLFolsomARAbsolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the atherosclerosis risk in communities (ARIC) studyCirculation2011123141501150821444879
   PubMed Web of Science ®Google Scholar
• BenjaminEJWolfPAD’AgostinoRBSilbershatzHKannelWBLevyDImpact of atrial fibrillation on the risk of death: the Framingham Heart StudyCirculation199898109469529737513
   PubMed Web of Science ®Google Scholar
• MiyasakaYBarnesMEBaileyKRMortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based studyJ Am Coll Cardiol200749998699217336723
   PubMed Web of Science ®Google Scholar
• WalkerRWDewhurstMGrayWKElectrocardiographic assessment of coronary artery disease and stroke risk factors in rural and urban Tanzania: a case-control studyJ Stroke Cerebrovasc Dis201423231532023545320
   PubMed Web of Science ®Google Scholar
• NieuwlaatRCapucciACammAJEuropean Heart Survey InvestigatorsAtrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on atrial fibrillationEur Heart J200526222422243416204266
   PubMed Web of Science ®Google Scholar
• KirchhofPAmmentorpBDariusHManagement of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events – European Registry in Atrial Fibrillation (PREFER in AF)Europace201416161424084680
   PubMed Web of Science ®Google Scholar
• ChiangCENaditch-BrûléLMurinJDistribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: insight from the real-life global survey evaluating patients with atrial fibrillation international registryCirc Arrhythm Electrophysiol20125463263922787011
   PubMed Web of Science ®Google Scholar
• Zoni-BerissoMLercariFCarazzaTDomenicucciSEpidemiology of atrial fibrillation: European perspectiveClin Epidemiol2014621322024966695
   PubMed Web of Science ®Google Scholar
• GageBFWatermanADShannonWBoechlerMRichMWRadfordMJValidation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial FibrillationJAMA2001285222864287011401607
   PubMed Web of Science ®Google Scholar
• LipGYNieuwlaatRPistersRLaneDACrijnsHJRefining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillationChest2010137226327219762550
   PubMed Web of Science ®Google Scholar
• FurieKLGoldsteinLBAlbersGWAmerican Heart Association Stroke CouncilCouncil on Quality of Care and Outcomes ResearchCouncil on Cardiovascular NursingCouncil on Clinical CardiologyCouncil on Peripheral Vascular DiseaseOral antithrombotic agents for the prevention of stroke in nonvalvular atrial fibrillation: a science advisory for healthcare professionals from the American Heart Association/American Stroke AssociationStroke201243123442345322858728
   PubMed Web of Science ®Google Scholar
• CammAJLipGYDe CaterinaRESC Committee for Practice Guidelines (CPG)2012Focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm AssociationEur Heart J201233212719274722922413
   PubMed Web of Science ®Google Scholar
• JanuaryCTWannLSAlpertJSACC/AHA Task Force Members2014 AHA/ACC/HRS Guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm SocietyJ Am Coll Cardiol20146421e1e7624685669
   PubMed Web of Science ®Google Scholar
• OldgrenJHealeyJSEzekowitzMRE-LY Atrial Fibrillation Registry InvestigatorsVariations in cause and management of atrial fibrillation in a prospective registry of 15 400 emergency department patients in 46 countries: the RE-LY Atrial Fibrillation RegistryCirculation2014129151568157624463370
   PubMed Web of Science ®Google Scholar
• DanesiMOkubadejoNOjiniFPrevalence of stroke in an urban, mixed-income community in Lagos, NigeriaNeuroepidemiology200728421622317851261
   PubMed Web of Science ®Google Scholar
• EnwerejiKONwosuMCOgunniyiANwaniPOAsomughaALEnwerejiEEEpidemiology of stroke in a rural community in Southeastern NigeriaVasc Health Risk Manag20141037538825028556
   PubMedGoogle Scholar
• GoASMozaffarianDRogerVLAmerican Heart Association Statistics Committee and Stroke Statistics SubcommitteeHeart disease and stroke statistics – 2014 update: a report from the American Heart AssociationCirculation20141293e28e29224352519
   PubMed Web of Science ®Google Scholar
• ZenebeGAlemayehuMAsmeraJCharacteristics and outcomes of stroke at Tikur Anbessa Teaching Hospital, EthiopiaEthiop Med J200543425125916523645
   PubMedGoogle Scholar
• JowiJOMativoPMPathological sub-types, risk factors and outcome of stroke at the Nairobi Hospital, KenyaEast Afr Med J2008851257258119413212
   PubMedGoogle Scholar
• CammAJLipGYDe CaterinaRESC Committee for Practice Guidelines-CPGDocument Reviewers2012Focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation – developed with the special contribution of the European Heart Rhythm AssociationEuropace201214101385141322923145
   PubMed Web of Science ®Google Scholar
• YouJJSingerDEHowardPAAmerican College of Chest PhysiciansAntithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelinesChest20121412 Supple531Se575S22315271
   PubMed Web of Science ®Google Scholar
• ConnollySJPogueJEikelboomJACTIVE W InvestigatorsBenefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic rangeCirculation2008118202029203718955670
   PubMed Web of Science ®Google Scholar
• MorganCLMcEwanPTukiendorfARobinsonPAClemensAPlumbJMWarfarin treatment in patients with atrial fibrillation: observing outcomes associated with varying levels of INR controlThromb Res20091241374119062079
   PubMed Web of Science ®Google Scholar
• HartRGPearceLAAguilarMIMeta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillationAnn Intern Med20071461285786717577005
   PubMed Web of Science ®Google Scholar
• DeZeeKJShimeallWTDouglasKMShumwayNMO’MalleyPGTreatment of excessive anticoagulation with phytonadione (vitamin K): a meta-analysisArch Intern Med2006166439139716505257
   PubMedGoogle Scholar
• HanleyJPWarfarin reversalJ Clin Pathol200457111132113915509671
   PubMed Web of Science ®Google Scholar
• Bristol-Myers SquibbCoumadin Prescribing Information2011 Available from: http://packageinserts.bms.com/pi/pi_coumadin.pdfAccessed October 11, 2013
   Google Scholar
• Boehringer IngelheimPradaxa^® (Dabigatran Etexilate Capsules) Prescribing Information2014 Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022512s017lbl.pdfAccessed September 18, 2013
   Google Scholar
• Janssen Pharmaceuticals IncXarelto^® (Rivaroxaban Tablets) Prescribing Information2014 Available from: http://www.xareltohcp.com/sites/default/files/pdf/xarelto_0.pdf#zoom=100Accessed March 8, 2014
   Google Scholar
• Bristol-Myers SquibbEliquis^® (Apixaban Tablets) Prescribing Information2014 Available from: http://packageinserts.bms.com/pi/pi_eliquis.pdfAccessed March 20, 2014
   Google Scholar
• Food and Drug AdministrationFDA Approves Anticlotting Drug Savaysa2015 Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm429523.htmAccessed January 8, 2015
   Google Scholar
• ConnollySJEzekowitzMDYusufSRE-LY Steering Committee and InvestigatorsDabigatran versus warfarin in patients with atrial fibrillationN Engl J Med2009361121139115119717844
   PubMed Web of Science ®Google Scholar
• GrangerCBAlexanderJHMcMurrayJJARISTOTLE Committees and InvestigatorsApixaban versus warfarin in patients with atrial fibrillationN Engl J Med20113651198199221870978
   PubMed Web of Science ®Google Scholar
• ConnollySJEikelboomJJoynerCAVERROES Steering Committee and InvestigatorsApixaban in patients with atrial fibrillationN Engl J Med2011364980681721309657
   PubMed Web of Science ®Google Scholar
• GiuglianoRPRuffCTBraunwaldEENGAGE AF-TIMI 48 InvestigatorsEdoxaban versus warfarin in patients with atrial fibrillationN Engl J Med2013369222093210424251359
   PubMed Web of Science ®Google Scholar
• WagenaarPNamibia becomes first country in Africa to launch dabigatran etexilate for atrial fibrillationCardiovasc J Afr201122528321983957
   PubMed Web of Science ®Google Scholar
• Kenya Pharmacy and Poisons BoardRegistered Human Drugs2014 Available from: http://pharmacyboardkenya.org/?p=513Accessed August 24, 2014
   Google Scholar
• Bayer’s Xarelto is approved in South Africa across five additional indicationsCardiovasc J Afr2014252909224977273
   PubMedGoogle Scholar
• Nigeria National Agency for Food and Drug Administration and ControlDrugs2015 Available from: http://www.nafdac.gov.ng/index.php/product-registration/registered-drugs?resetfilters=0Accessed February 20, 2015
   Google Scholar
• Uganda National Drug AuthorityDrug Register2014 Available from: http://www.nda.or.ug/hmn_list.phpAccessed August 25, 2014
   Google Scholar
• Medicines Control Authority of ZimbabweMedicines Registers2014 Available from: http://www.mcaz.co.zw/index.php/downloads/category/17-registersAccessed August 25, 2014
   Google Scholar
• BryerAConnorMHaugPSouth African guideline for management of ischaemic stroke and transient ischaemic attack 2010: a guideline from the South African Stroke Society (SASS) and the SASS Writing CommitteeS Afr Med J201010011 pt 274777821081029
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical ExcellenceAtrial Fibrillation: The Management of Atrial Fibrillation [cg180]2014 Available from: guidance.nice.org.uk/cg180Accessed September 2, 2014
   Google Scholar
• MeschiaJFBushnellCBoden-AlbalaBAmerican Heart Association Stroke CouncilCouncil on Cardiovascular and Stroke NursingCouncil on Clinical CardiologyCouncil on Functional Genomics and Translational BiologyCouncil on HypertensionGuidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke AssociationStroke201445123754383225355838
   PubMed Web of Science ®Google Scholar
• SzucsTDBramkampMPharmacoeconomics of anticoagulation therapy for stroke prevention in atrial fibrillation: a reviewJ Thromb Haemost2006461180118516706956
   PubMed Web of Science ®Google Scholar
• BirabiBNOkeKIDienyePOOkaforUCCost burden of post stroke condition in Nigeria: a pilot studyGlob J Health Sci201246172223121738
   PubMedGoogle Scholar
• BerghMMaraisCAMiller-JansonHSalieFStanderMPEconomic appraisal of dabigatran as first-line therapy for stroke prevention in atrial fibrillationS Afr Med J2013103424124523547700
   PubMed Web of Science ®Google Scholar
• DalbyAJWesselsPOpieLHWarfarin in non-valvular atrial fibrillationS Afr Med J20131031290190424300625
   PubMed Web of Science ®Google Scholar
• World BankPoverty and Equity Regional Dashboard for Sub-Saharan Africa2014 Available from: http://povertydata.worldbank.org/poverty/region/SSAAccessed September 2, 2014
   Google Scholar
• BhagatKTisockiKPrescribing patterns for the use of antithrombotics in the management of atrial fibrillation in ZimbabweCent Afr J Med1999451128729010892453
   PubMedGoogle Scholar
• JardineRMFineJObelIWA survey on the treatment of atrial fibrillation in South AfricaS Afr Med J2014104962362725212404
   PubMed Web of Science ®Google Scholar
• AalbersJSouth Africa’s poor warfarin control raises questions of benefit above other anticoagulant therapies in atrial fibrillationCardiovasc J Afr201122422021881695
   PubMed Web of Science ®Google Scholar
• SingerDEHellkampASPicciniJPROCKET AF InvestigatorsImpact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trialJ Am Heart Assoc201321e00006723525418
   PubMed Web of Science ®Google Scholar
• WallentinLLopesRDHannaMApixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) InvestigatorsEfficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillationCirculation2013127222166217623640971
   PubMed Web of Science ®Google Scholar
• NjovaneXWFasinuPSRosenkranzBComparative evaluation of warfarin utilisation in two primary healthcare clinics in the Cape Town areaCardiovasc J Afr2013242192323750346
   PubMed Web of Science ®Google Scholar
• KakkarAKMuellerIBassandJPInternational longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD)Am Heart J20121631131922172431
   PubMed Web of Science ®Google Scholar
• Thrombosis Research Institute LondonGARFIELD-AF Status2014 Available from: http://www.tri-london.ac.uk/garfield/statusAccessed November 17, 2014
   Google Scholar
• CammAJBreithardtGCrijnsHReal-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation)J Am Coll Cardiol201158549350121777747
   PubMed Web of Science ®Google Scholar
• BalabanovaDMillsAContehLGood health at low cost 25 years on: lessons for the future of health systems strengtheningLancet201338198832118213323574803
   PubMed Web of Science ®Google Scholar
• NorrvingBKisselaBThe global burden of stroke and need for a continuum of careNeurology2013803 Suppl 2S5S1223319486
   PubMed Web of Science ®Google Scholar
• SingerDEAlbersGWDalenJEAmerican College of Chest PhysiciansAntithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Chest20081336 Suppl546S592S18574273
   PubMed Web of Science ®Google Scholar
• RabkinMMelakuZBruceKStrengthening health systems for chronic care: leveraging HIV programs to support diabetes services in Ethiopia and SwazilandJ Trop Med2012201213746023056058
   PubMedGoogle Scholar
• PatelMRMahaffeyKWGargJROCKET AF InvestigatorsRivaroxaban versus warfarin in nonvalvular atrial fibrillationN Engl J Med20113651088389121830957
   PubMed Web of Science ®Google Scholar